|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-4-24
|
|
pubmed:abstractText |
To investigate whether the addition of weekend chemotherapy consisting of carboplatin/etoposide to hyperfractionated radiation therapy (Hfx RT) and concurrent daily carboplatin/etoposide offers an advantage over the same Hfx RT/daily carboplatin/etoposide.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
19-25
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11316542-Adult,
pubmed-meshheading:11316542-Aged,
pubmed-meshheading:11316542-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11316542-Carboplatin,
pubmed-meshheading:11316542-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11316542-Combined Modality Therapy,
pubmed-meshheading:11316542-Disease-Free Survival,
pubmed-meshheading:11316542-Dose Fractionation,
pubmed-meshheading:11316542-Dose-Response Relationship, Drug,
pubmed-meshheading:11316542-Dose-Response Relationship, Radiation,
pubmed-meshheading:11316542-Drug Administration Schedule,
pubmed-meshheading:11316542-Etoposide,
pubmed-meshheading:11316542-Female,
pubmed-meshheading:11316542-Humans,
pubmed-meshheading:11316542-Lung Neoplasms,
pubmed-meshheading:11316542-Male,
pubmed-meshheading:11316542-Middle Aged,
pubmed-meshheading:11316542-Prospective Studies,
pubmed-meshheading:11316542-Radiotherapy,
pubmed-meshheading:11316542-Survival Rate
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.
|
|
pubmed:affiliation |
Department of Oncology, University Hospital, Kragujevac, Yugoslavia. bjeremic@med.uni-tuebingen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
